(1)
Albareda, N.; Rosenberg, N.; Roth, S.; Zsolt, I.; Rosen, T.; Hebert, A. A. Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Phase III Clinical Trials Pooled Analysis Results. J of Skin 2017, 1, s102.